Accrued expenses consist of the following (in thousands):
December 31, 2017
December 31, 2016
External research and preclinical development
$
5,875
3,290
Employee compensation and benefits
2,494
1,911
Professional fees
1,225
819
Facilities
134
90
Restricted stock liability
—
5
9,728
6,115
No definition available.
Tabular disclosure of the components of accrued liabilities.